brain disease
DESCRIPTION
Summary of common diseasesTRANSCRIPT
BRAIN DISEASE DEFINITION SYMPTOMS/TYPES NEUROPATHOLOGY MEDICATIONS
ALZHEIMER’S DISEASE The most common form of dementia
affecting the elderly
MEMORY LOSS
PERSONALITY CHANGES
PARANOIA
Atrophy at these Areas:
LIMBIC SYSTEM
1. Hippocampus (glutamate)
2. Entorhinal cortex (glutamate)
CHOLINERGIC BASAL NUCLEUS OF MEYNERT
MEDIAL SEPTUM
SEROTONERGIC ANTERIOR RAPHE
NORADRENERGIC LOCUS CERULEUS
NEOCORTEX
Lesion formation from:
Extracellular deposits of fibrous amyloid protein
1. Amyloid peptide forms senile plaques
2. It is made from APP
3. APP regulate neurite formation, cell adhesion and
ion transport (Cu and Zn)
4. Mutant APP751 forms β-amyloid plaques,
tau-positive tangles which leads to memory
impairments
5. APP could either be cleaved byα-APP secretase to
lead to harmless results or β-APP secretase to
generate β-amyloid proteins
6. Aggregated β-amyloid proteins are known to kill
neurons by apoptosis
7. Mutations in presenelin 1 and 2 genes may lead to
early forms of Alzheimer’s disease.
Intracellular deposit of hyper phosphorylated tau
proteins, forming NFTs (Neurofibrillary tangles).
1. Tau proteins bind to β-tubulins to stabilize
microtubules involved in axoplasmic transport.
2. Hyper phosphorylated tau proteins assembles to
form paired helical filaments which forms NFTs
3. Tau load is the best predicator for cognitive decline
in AD
Neuroinflammation
Presence of activated microglial cells and astrocytes
Amyloid fibres not only being toxic to neurons directly,
it also indirectly activates microglia to secrete
molecules to kill neurons.
TACRINE
ARICEPT
MEMANTINE
PARKINSON’S DISEASE A very severe neurodegenerative disorder RIGIDITY
AKINESIA
TREMOR AT REST
EMOTIONALLY FLAT
Loss of dopamine neurons in the SNc and dopamine
terminals in the striatum
Over-excitation of cholinergic neurons in the striatum
(akinesia)
Increased glutamate activity in subthalamic
nucleus????
L-DOPA (+ CARBIDOPA)
BENZTROPINE
BROMOCRIPTINE
SCHIZOPHRENIA A disease of abnormal thought,
perception, behaviour and attention.
DEREALIZATION
DEPERSONALIZATION
Schizophrenic symptoms due to over activity of dopamine
systems and down decrease in activity of glutamate
systems in the mesolimbic/cortical systems.
TYPICAL:
CHLORPRAMAZINE
HALOPERIDOL
ATYPICAL
CLOZAPINE
RISPERIDONE
POSITIVE SYMPTOMS NEGATIVE SYMPTOMS
Delusions
Auditory
Hallucinations
Withdrawal
Flattened Mood
ANXIETY An unpleasant state accompanied by
apprehension, worry, fear,
nervousness etc.
GENERALIZED ANXIETY DISORDERS
OCDs
PHOBIAS
PANIC ATTACKS
INCREASED SEROTONIN RELEASE FROM THE RAPHE
NUCLEUS
DECREASED ACTIVITY OF GABAA RECEPTORS
ANTI-ANXIOLYTICS
DIAZEPAM (BENZODIAZEPINE)
MIDAZOLAM (BENZODIAZEPINE)
FLUMAZENIL (BZ ANTAGONIST)
BUSPIRONE
DEPRESSION An episodic, recurrent illness with
periods of spontaneous remission
UNIPOLAR
Decrease in mood, appetite, libido
Tiredness
ENDOGENOUS DEPRESSION: unknown origin
REACTIVE DEPRESSION: Life/environment
based
BIPOLAR
Mood Fluctuates between depression and
mania
Genetic basis
MANIA: Heightened mood/euphoria,
irritability, poor insight into sudden irrational
decisions and some cases delusions and
hallucinations
SIMPLE MONOAMINE THEORY
Depression is a result of decrease in brain monoamines
(NA, DA, 5-HT)
Thus Monoamine Inactivation Systems:
Re-uptake into the neurons
Metabolism by MAOA and MAOB enzymes
Anti-depressants inhibit the above two systems
ANTI-DEPRESSANTS
LITHIUM CARBONATE
1ST GENERATION 2ND GENERATION
TRICYCLICS
AMITRIPTYLLINE
IMIPRAMINE
MAO INHIBITORS
PHENELZINE
MAO INHIBITORS
MOCLOBEMIDE
SSRI
FLUOXETINE
PAROXETINE
EPILEPSY A group of brain disorders
characterised by abnormal
synchronous high frequency and
neuronal discharge (seizure) that is
spontaneous and recurrent.
Types of seizures (epilepsy):
PARTIAL SEIZURES
Localised to some brain regions, have a
“Focus”.
- Simple: No loss of consciousness
- Complex: Loss of consciousness
GENERALISED SEIZURES
Takes place everywhere, have no “Focus”.
- Petit Mal: Absence seizure, spike and wave,
common in children.
- Grand Mal: Tonic/Clonic seizures. Involves:
1. Trunk & limb movements
2. Jerking of muscles
Insufficient GABAA activity.
Excessive neuronal discharge
IDIOPATHIC
No known cause
SYMPTOMATIC
Result of tumour/infection/injury
ANTI-EPILEPTICS
PHENOBARBITONE
PHENYTOIN
CARBAMAZEPINE
SODIUM VALPORATE
DIAZEPAM
LAMOTRIGINE
MEMANTINE (SE)
STATUS EPILEPTICUS (SE)
Medical emergency
>20min (prolonged + seizure) get to brain
damage
Can be partial/convulsive SE or Absence SE
HUNTINGTON’S DISEASE A neurodegenerative genetic disorder
that affects muscle coordination and
leads to cognitive decline and
psychiatric problems.
BEHAVIOURAL/COGNITIVE CHANGES
HYPERKINESIA
HYPOKINESIA AT LATE STAGE
INVOLUNTARY MOVEMENTS
Loss of GABAergic projection neurons in the striatum
N/A
AMYOTROPHIC LATERAL
SCLEROSIS (AKA
ALS/MOTOR NEURON
DISEASE)
Adult onset chronic
neurodegenerative disorder with the
characteristic of degeneration of
upper and lower motor neurons.
MUSCLE WASTING
WEAKNESS
SPASTICITY
PARALYSIS
DEATH DUE TO RESPIRATORY MUSCLE
PARALYSIS
GLUTAMATE EXCITOTOXICITY
1. Loss of astrocytic EAAT2 (removes glutamate from the
synapse) in the motor neuron and spinal cord
2. Increases glutamate levels at the synapses
3. Causes over action of neuronal NMDA receptors and
AMPA receptors
4. Increases intracellular Ca2+ as well as Na+/Cl- ions
5. Influx of water
6. Death of motor neurons
7. Symptoms of ALS
RILUZOLE
OBESSIVE COMPULSIVE
DISORDERS
Anxiety disorders characterized by
intrusive thoughts that produce
uneasiness, apprehension, fear or
worry, repetitive actions aimed at
reducing the associated anxiety.
REPETITIVE ACTIONS (COMPULSIONS)
REPETITIVE THOUGHTS (OBSESSIONS)
Mutation in the serotonin transporter.
Mutation causes gain-of-function leading to increased
serotonin
Unclear????
SSRIs (FLUOXETINE)